Please enable js

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.

lungs lungs

Pneumococcal pneumonia can be serious.

Pneumococcal pneumonia can be serious.

You may be at increased risk for pneumococcal pneumonia depending on your age and health conditions.

Learn more about pneumococcal pneumonia
bandage bandage

Get vaccinated to help protect yourself.

Get vaccinated to help protect yourself.

Talk to your doctor or pharmacist about getting vaccinated with Prevnar 20TM.

Get started now
chat chat

Start the conversation.

Start the conversation.

Ask your doctor or pharmacist about Prevnar 20TM.

Learn more

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

  • Prevnar 20TM should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20TM or to diphtheria toxoid
  • Adults with weakened immune systems may have a lower response to Prevnar 20TM. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20TM is right for you
  • In adults 18 years of age and older, the most common side effects were pain at the injection site, muscle pain, fatigue, headache, and joint pain. Additionally, injection site swelling was also common in adults 18 through 59 years of age
  • Ask your healthcare provider about the risks and benefits of Prevnar 20TM. Only a healthcare provider can decide if Prevnar 20TM is right for you

Please click here for Prevnar 20TM Full Prescribing Information. Full Prescribing Information is also available at https://www.prevnar20.com.

INDICATION FOR PREVNAR 20TM

  • Prevnar 20TM is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in adults 18 years of age and older
  • The indication for preventing pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F is approved based on immune responses. Continued approval may depend on a supportive study

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1‐800‐822‐7967.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

  • Prevnar 20TM should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20TM or to diphtheria toxoid
  • Adults with weakened immune systems may have a lower response to Prevnar 20TM. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20TM is right for you
  • In adults 18 years of age and older, the most common side effects were pain at the injection site, muscle pain, fatigue, headache, and joint pain. Additionally, injection site swelling was also common in adults 18 through 59 years of age
  • Ask your healthcare provider about the risks and benefits of Prevnar 20TM. Only a healthcare provider can decide if Prevnar 20TM is right for you

Please click here for Prevnar 20TM Full Prescribing Information. Full Prescribing Information is also available at https://www.prevnar20.com.

INDICATION FOR PREVNAR 20TM

  • Prevnar 20TM is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in adults 18 years of age and older
  • The indication for preventing pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F is approved based on immune responses. Continued approval may depend on a supportive study

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1‐800‐822‐7967.